ATHENasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as PRNAF
ALTERITY THERAPEUTICS LTD
Financials through fiscal 2026, year ended Jun 30, 2026Last filing: 20-F on Aug 28, 2026
$2.43−0.19 (-7.25%)
Close on Oct 19, 2026
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
0M
Shares held, 13F filers
Institutional holders
22
7 new, 0 sold out
Net institutional buying
0M
In Q2 2026
Insider trades, 12 months
1 buys · 0 sales
Net bought $23.81K
Shares held by institutions
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of ATHE | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Twin Lakes Capital Management, LLC | 139,258 | – | $747.82K | – | 0.29% |
| Morgan Stanley | 63,065 | – | $338.66K | +4,683 | 0.00% |
| Greenleaf Trust | 62,000 | – | $332.94K | +30,000 | 0.00% |
| HB Wealth Management, LLC | 58,460 | – | $313.93K | – | 0.00% |
| Citadel Advisors LLC | 37,597 | – | $201.90K | +17,520 | 0.00% |
| Hrt Financial LP | 17,292 | – | $92 | New | 0.00% |
| Bnp Paribas Arbitrage, Snc | 10,239 | – | $54.98K | +3,430 | 0.00% |
| GAMMA Investing LLC | 2,309 | – | $12.40K | +453 | 0.00% |
| Rhumbline Advisers | 2,009 | – | $10.79K | +39 | 0.00% |
| Acadian Asset Management LLC | 1,863 | – | $10 | – | 0.00% |
| Providence Capital Advisors, LLC | 200 | – | $1.07K | New | 0.00% |
| Integrated Wealth Concepts LLC | 73 | – | $392 | New | 0.00% |
| Osaic Holdings, Inc. | 68 | – | $362 | – | 0.00% |
| Ronald Blue Trust, Inc. | 40 | – | $215 | – | 0.00% |
| Farther Finance Advisors, LLC | 39 | – | $205 | +17 | 0.00% |
| CoreCap Advisors, LLC | 21 | – | $113 | – | 0.00% |
| Steward Partners Investment Advisory, LLC | 6 | – | $32 | – | 0.00% |
| UBS Group AG | 5 | – | $27 | New | 0.00% |
| Danske Bank A/S | 1 | – | $5 | – | 0.00% |
| Cranbrook Wealth Management, LLC | 1 | – | $6 | New | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|
| Q2 2026 | 22 | 0M | 7 / 7 | 0 / 0 | 0M | 0M |
| Q1 2026 | 15 | 0M | 0 / 2 | 5 / 2 | 0M | 0M |
| Q4 2025 | 18 | 0M | 4 / 1 | 5 / 2 | 0M | 0M |
| Q3 2025 | 16 | 0M | 6 / 4 | 2 / 1 | 0M | 0M |
| Q2 2025 | 11 | 0M | 2 / 1 | 1 / 3 | 0M | 0M |
| Q1 2025 | 12 | 0M | 2 / 4 | 1 / 2 | 0M | 0M |
| Q4 2024 | 13 | 0M | 3 / 2 | 2 / 3 | 0M | 0M |
| Q3 2024 | 13 | 0M | 4 / 1 | 2 / 1 | 0M | 0M |
| Q2 2024 | 10 | 0M | 2 / 0 | 1 / 2 | 0M | 0M |
| Q1 2024 | 10 | 0M | 4 / 1 | 0 / 2 | 0M | 0M |
| Q4 2023 | 9 | 0M | 3 / 1 | 0 / 1 | 0M | 0M |
| Q3 2023 | 7 | 0M | 1 / 0 | 1 / 1 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of ATHE | Value | % of fund | As of |
|---|---|---|---|---|---|
| Fidelity Nasdaq Composite Index Fund | 1,155 | – | $4.76K | 0.00% | May 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | Latest filing |
|---|---|---|---|
| David Allen Stamler | Chief Executive Officer, Director | 11,827,570 | Sep 8, 2026 |
| Niven Abby Sarah Macnish | Chief Financial Officer | 454,545 | Apr 9, 2026 |
| Peter Ashley Marks | Director | 191,340 | Sep 8, 2026 |
| Lawrence Bernard Gozlan | Director | 4,545,455 | Jun 23, 2026 |
| Julian Michael Babarczy | Director | – | Jun 23, 2026 |
| Ann Michelle Cunningham | Director | – | Apr 29, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Peter Ashley Marks Director | Aug 31, 2026 | Buy | +47,620 | $0.50 | $23.81K | 191,340 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.